Linh Vuong
Adolescent Medicine · Walnut Creek, CANPI 1922856111
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations.
Across 54 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$143
- GSK$138
- Amgen$115
- Bayer$79
- Novo Nordisk$76
- Dexcom, Inc.$75
- plus $684 from 20 others
What the payments were for
- Food & beverage$1,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $143 |
| GSK | 6 | $138 |
| Amgen | 5 | $115 |
| Bayer | 4 | $79 |
| Novo Nordisk | 3 | $76 |
| Dexcom, Inc. | 2 | $75 |
| Boehringer Ingelheim | 3 | $62 |
| Radius Health, Inc. | 2 | $60 |
| Novartis | 2 | $58 |
| Exact Sciences | 2 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Fresenius Kabi USA, LLC | 1 | $35 |
| Madrigal Pharmaceuticals | 2 | $32 |
| Averitas Pharma Inc. | 1 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| AbbVie | 1 | $26 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| CSL Behring | 1 | $21 |
| Sanofi | 1 | $17 |
| ZOLL Respicardia, Inc. | 1 | $13 |
How this compares
$1,310 in reported general payments places this provider in the 85th percentile of 202 adolescent medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 20 | $33,623 |
| OzempicSemaglutide | 24 | $33,257 |
| MounjaroTirzepatide | 14 | $23,638 |
| SynthroidLevothyroxine Sodium | 13 | $970 |
| Rosuvastatin Calcium | 27 | $699 |
| Levothyroxine Sodium | 48 | $695 |
| Metoprolol Succinate | 15 | $318 |
| Atorvastatin Calcium | 40 | $313 |
| Metformin Hcl | 24 | $287 |
| Omeprazole | 14 | $280 |
| Metformin Hcl ErMetformin Hcl | 13 | $219 |
| Gabapentin | 11 | $196 |
| Losartan Potassium | 20 | $188 |
| Lisinopril | 20 | $157 |
| Amlodipine Besylate | 32 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $62 | $33,62320 claims |
| Novo NordiskOzempic | $76 | $33,25724 claims |
| Lilly USA, LLCMounjaro | $29 | $23,63814 claims |
| AbbVieSynthroid | $26 | $97013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 202 adolescent medicine providers in California.
Other adolescent medicine in Walnut Creek
- Leman YelOrange$89K
- Michelle RolandLos Angeles$22K
- Venu Prabakerla Mesa$15K
- Kanani TitchenSan Diego$8K
- David NguyenFountain Valley$6K
- Anahit BlikianGlendale$5K
- Lisa LawSan Francisco$5K
- Marilou CruzDowney$5K
- Albina BenabayeStockton$5K
- Mohamad KadriLos Angeles$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.